Developing a mass spectrometric assay to measure granulin peptides in CSF for progranulin‐associated frontotemporal dementia
Imogen J. Swift(UK Dementia Research Institute), Johan Gobom(Sahlgrenska University Hospital), Ann Brinkmalm(Sahlgrenska University Hospital), Caroline Graff(Karolinska Institutet), Maria Carmela Tartaglia, James B. Rowe(MRC Cognition and Brain Sciences Unit), Alexander Gerhard(University of Manchester), Christopher Butler(Pontificia Universidad Católica de Chile), Matthis Synofzik(German Center for Neurodegenerative Diseases), Johannes Levin(The University of Melbourne), Sophia Weiner(Institute of Neurobiology), Alexandre de Mendonça(University of Lisbon), Isabelle Le Ber(Inserm), Raquel Sánchez‐Valle(Biomedical Research Networking Center on Neurodegenerative Diseases), Mathias Sauer(Sahlgrenska University Hospital), Harro Seelaar(Erasmus MC), Aitana Sogorb‐Esteve(UK Dementia Research Institute), Pietro Tiraboschi(Mayo Clinic in Florida), Florence Pasquier(Centre Hospitalier Universitaire de Lille), Isabel Santana(Hospitais da Universidade de Coimbra), Lize C. Jiskoot(Erasmus MC), Jonathan D. Rohrer(University Memory and Aging Center), Markus Otto(University Hospital in Halle), Rik Vandenberghe(Allen Institute for Brain Science), Johanna Nilsson(University of Gothenburg), Elizabeth Finger(Western University), Henrik Zetterberg(University of Wisconsin–Madison), Daniela Galimberti(University of Milan), Fermín Moreno(Instituto de Salud Carlos III), Robert Laforce(Université Laval), Barbara Borroni(Centro San Giovanni di Dio Fatebenefratelli), Mario Masellis(Sunnybrook Health Science Centre), Simon Ducharme(Montreal Neurological Institute and Hospital), John C. van Swieten(Erasmus MC), Sandro Sorbi(University of Florence)
Cited by 0
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k